Last reviewed · How we verify
Mobilization with movement
Mobilization with movement is a Biologic drug developed by Eleuterio Atanasio Sánchez Romero. It is currently in Phase 1 development.
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Mobilization with movement |
|---|---|
| Sponsor | Eleuterio Atanasio Sánchez Romero |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- IASTM and Vibration Effects on Pain, Functionality, and Kinesiophobia in Lumbar Disc Herniation (NA)
- Blood Flow Restriction Training Versus Mulligan Technique in Treatment of Lateral Epicondylitis (NA)
- Combined Effects of MWM and Tendon Gliding Exercises in Smartphone Users With De Quervain's Tenosynovitis (NA)
- Acute Effects of Posterior Talar Glide Mobilization (NA)
- Comparison of the Effects of Different Chest Techniques on University Students With Smoking Addiction (NA)
- Effectiveness and Efficiency of an Upper Limb Active-Passive Exoskeleton Robot in Patients With Frozen Shoulder (NA)
- Effects of Lower Extremity Neural Mobilization on Gait Biomechanics and Spinal Alignment (NA)
- Comparison of ESWT and Deep Tissue Massage in Individuals With Medial Tibial Stress Syndrome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mobilization with movement CI brief — competitive landscape report
- Mobilization with movement updates RSS · CI watch RSS
- Eleuterio Atanasio Sánchez Romero portfolio CI
Frequently asked questions about Mobilization with movement
What is Mobilization with movement?
Who makes Mobilization with movement?
What development phase is Mobilization with movement in?
Related
- Manufacturer: Eleuterio Atanasio Sánchez Romero — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing